Insiders · Profile

Kirn David

See Remarks at 4D Molecular Therapeutics. Filing since 15 Dec 2022. CIK 0001834021

Company

Date

Role

Action

Shares

Amount

Of holding

FDMT 4D Molecular Therapeutics, Inc.

5 Oct 2026

See Remarks

Sold on a plan

58,333

$753.94K

7.6%

FDMT 4D Molecular Therapeutics, Inc.

14 Sep 2026

See Remarks

Sold on a plan

58,333

$811.00K

7.1%

FDMT 4D Molecular Therapeutics, Inc.

19 Aug 2026

See Remarks

Sold on a plan

69,076

$1.09M

7.7%

FDMT 4D Molecular Therapeutics, Inc.

4 Aug 2026

See Remarks

Sold on a plan

26,842

$274.60K

3.1%

FDMT 4D Molecular Therapeutics, Inc.

3 Aug 2026

See Remarks

Sold on a plan

12,415

$124.72K

1.4%

FDMT 4D Molecular Therapeutics, Inc.

10 Jul 2026

See Remarks

Sold on a plan

15,725

$189.23K

1.7%

FDMT 4D Molecular Therapeutics, Inc.

9 Jul 2026

See Remarks

Sold on a plan

42,608

$548.18K

4.5%

FDMT 4D Molecular Therapeutics, Inc.

22 Jun 2026

See Remarks

Sold on a plan

114,746

$1.20M

10.9%

FDMT 4D Molecular Therapeutics, Inc.

1 Jun 2026

See Remarks

Sold on a plan

1,922

$19.26K

0.2%

FDMT 4D Molecular Therapeutics, Inc.

10 Jul 2024

Chief Executive Officer

Sold on a plan

12,923

$290.60K

1.2%

FDMT 4D Molecular Therapeutics, Inc.

24 Jun 2024

Chief Executive Officer

Sold on a plan

12,930

$298.71K

1.2%

FDMT 4D Molecular Therapeutics, Inc.

8 Feb 2024

Chief Executive Officer

Sold on a plan

92,001

$2.50M

8.0%

FDMT 4D Molecular Therapeutics, Inc.

23 Jan 2024

Chief Executive Officer

Sold at will

5,696

$104.85K

0.5%

FDMT 4D Molecular Therapeutics, Inc.

5 Jan 2024

Chief Executive Officer

Sold on a plan

28,237

$552.48K

2.4%

FDMT 4D Molecular Therapeutics, Inc.

4 Jan 2024

Chief Executive Officer

Sold on a plan

40,732

$827.20K

3.3%

FDMT 4D Molecular Therapeutics, Inc.

18 Dec 2023

Chief Executive Officer

Sold on a plan

4,702

$85.24K

0.4%

FDMT 4D Molecular Therapeutics, Inc.

15 Dec 2023

Chief Executive Officer

Sold on a plan

28,632

$494.43K

2.3%

FDMT 4D Molecular Therapeutics, Inc.

22 Feb 2023

Chief Executive Officer

Sold, plan not stated

16,449

$332.66K

0.9%

FDMT 4D Molecular Therapeutics, Inc.

21 Feb 2023

Chief Executive Officer

Sold, plan not stated

17,997

$377.21K

1.0%

FDMT 4D Molecular Therapeutics, Inc.

20 Jan 2023

Chief Executive Officer

Sold, plan not stated

8,625

$174.13K

0.5%

FDMT 4D Molecular Therapeutics, Inc.

19 Jan 2023

Chief Executive Officer

Sold, plan not stated

10,899

$218.35K

0.6%

FDMT 4D Molecular Therapeutics, Inc.

16 Dec 2022

Chief Executive Officer

Sold, plan not stated

53,944

$1.24M

2.7%

FDMT 4D Molecular Therapeutics, Inc.

15 Dec 2022

Chief Executive Officer

Sold, plan not stated

32,933

$776.77K

1.6%

23 decisions on file.